The Use of Voxelotor for the Management of Sickle Cell Disease

In this podcast, Nirmish Shah, MD, speaks about real-world experience of voxelotor for the management of complications in sickle cell disease, including if voxelator helps improve hemoglobin. He also presented on this topic at the 63rd ASH Annual Meeting & Exposition.

Additional Resource:

• Shah N, Lipato T, Alvarez OA, et al. Real-world experience of voxelotor for the management of complications in sickle cell disease. Paper presented at: 63rd American Society of Hematology Annual Meeting & Exposition; December 11-13, 2021; Virtual. https://ash.confex.com/ash/2021/webprogram/Paper153138.html 

Nirmish Shah, MD, is the director of the sickle cell transition program and the director of clinical research in benign hematology at Duke University School of Medicine (Durham, North Carolina).